Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Companies / Poland

Poland Slashes Prices Of Reimbursable Medicines

July 2006 | Market Trend Analysis

Because of unfavourable currency exchange rates, almost half of 2,500 products on Poland's reimbursement list had their prices reduced by 8% at the beginning of July 2006. The development - which should result in savings of PLN400mn (US$130mn) for the national insurance fund - has been welcomed by patients but strongly criticised by an industry leader.

Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.

[
: *
[
: *


If you would like to subscribe to Emerging Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.

If you would like to take a trial to Emerging Europe Pharma & Healthcare Insight please click on the trial link below.

Free Trial To Pharmaceuticals & Healthcare Insight

TAKE A TRIAL >>
Emerging Europe InsightEmerging Europe Channels Emerging Europe Countries